Beijing Aosaikang Pharmaceutical Co., Ltd.

XSEC:002755 Stock Report

Market Cap: CN¥11.0b

Beijing Aosaikang Pharmaceutical Balance Sheet Health

Financial Health criteria checks 4/6

Beijing Aosaikang Pharmaceutical has a total shareholder equity of CN¥3.1B and total debt of CN¥70.0M, which brings its debt-to-equity ratio to 2.3%. Its total assets and total liabilities are CN¥3.8B and CN¥732.3M respectively.

Key information

2.3%

Debt to equity ratio

CN¥70.03m

Debt

Interest coverage ration/a
CashCN¥1.95b
EquityCN¥3.08b
Total liabilitiesCN¥732.35m
Total assetsCN¥3.81b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 002755's short term assets (CN¥2.4B) exceed its short term liabilities (CN¥652.4M).

Long Term Liabilities: 002755's short term assets (CN¥2.4B) exceed its long term liabilities (CN¥79.9M).


Debt to Equity History and Analysis

Debt Level: 002755 has more cash than its total debt.

Reducing Debt: 002755's debt to equity ratio has increased from 0% to 2.3% over the past 5 years.

Debt Coverage: 002755's debt is well covered by operating cash flow (523.1%).

Interest Coverage: Insufficient data to determine if 002755's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies